As of 2025-09-18, the EV/EBITDA ratio of THC Biomed Intl Ltd (THC.CN) is -3.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. THC.CN's latest enterprise value is 6.24 mil CAD. THC.CN's TTM EBITDA according to its financial statements is -2.03 mil CAD. Dividing these 2 quantities gives us the above THC.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.4x - 16.5x | 9.7x |
| Forward P/E multiples | 7.9x - 11.7x | 11.0x |
| Fair Price | (0.24) - 0.10 | (0.10) |
| Upside | -1294.0% - 422.8% | -605.5% |
| Date | EV/EBITDA |